 |
PDBsum entry 3qrk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qrk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Conformational control inhibition of the bcr-Abl1 tyrosine kinase, Including the gatekeeper t315i mutant, By the switch-Control inhibitor dcc-2036.
|
|
|
Authors
|
|
W.W.Chan,
S.C.Wise,
M.D.Kaufman,
Y.M.Ahn,
C.L.Ensinger,
T.Haack,
M.M.Hood,
J.Jones,
J.W.Lord,
W.P.Lu,
D.Miller,
W.C.Patt,
B.D.Smith,
P.A.Petillo,
T.J.Rutkoski,
H.Telikepalli,
L.Vogeti,
T.Yao,
L.Chun,
R.Clark,
P.Evangelista,
L.C.Gavrilescu,
K.Lazarides,
V.M.Zaleskas,
L.J.Stewart,
R.A.Van etten,
D.L.Flynn.
|
|
|
Ref.
|
|
Cancer Cell, 2011,
19,
556-568.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
